"I'm wildly bullish, and I may be dead wrong, but I'm wildly bullish."
As an investor, I've come across an intriguing statistic that has piqued my curiosity. CytoDyn, a biotech company specializing in innovative therapies, is currently facing a federal indictment. With their former CEO under scrutiny for issuing false statements and misleading documents, the company has found …
The recent initial public offering (IPO) of Monogram Orthopedics has resulted in a significant surge in the company's stock prices. Monogram Orthopedics' shares experienced a remarkable increase of up to 317%, with the stock opening at $38 and reaching an early high of $48.99. Despite …
Stryker Corporation, a prominent player in the medical technologies industry, has garnered widespread attention due to its substantial market capitalization of over $100 billion. With its strong presence in the market, Stryker's revenue streams are primarily derived from its MedSurg & Neurotechnology division, accounting for …
NIO, a prominent player in the electric vehicle industry, has recently announced a substantial strategic equity investment of 2.2 billion dollars from CYVN. This sizable financial boost is expected to have a significant impact on NIO's expansion plans and operational capabilities. At a time when …
In a surprising turn of events, Walmart's CEO has made a massive stock sale that has sent shockwaves through the market. This significant stock sale has raised questions and speculation about its potential impact on the company's stock performance and overall market perception. As one …
Despite fierce competition in the financial market, SoFi has emerged as a dominant player with its innovative range of financial products. This leading financial technology company has captivated customers with its diverse offerings and customer-centric approach. SoFi's success can be attributed to its unwavering commitment …
Geron's Imetelstat has emerged as a potential game-changer in the field of hematological cancers. Despite facing competition from other pharmaceutical companies and safety concerns regarding discontinuation rates, this telomerase inhibitor aims to halt the proliferation of malignant hematopoietic stem cells. Geron is the only company …
Renowned money manager Julian Robertson has recently issued a warning about a potential market collapse, sparking interest and concern among investors and industry professionals. With an impressive track record and successful Tiger Management fund, Robertson's insights hold weight in the finance world. He expresses apprehension …
In the highly competitive arena of large-cap exchange-traded funds (ETFs), two formidable contenders have emerged: SCHX and VOO. Boasting total assets of over $29B and $264B respectively, these funds have established their credibility and size in the market. With SCHX tracking the Dow Jones US …
Berkshire Hathaway, the multinational conglomerate led by renowned investor Warren Buffett, has reported impressive financial results for the third quarter of the year. With operating earnings soaring by 41% compared to the same period last year, the company's insurance businesses have played a significant role …